Beyond cost what will shape India’s pharma competitiveness?
Christoph Funke, Chief Technical Operations Officer, Lupin, explains why India’s pharma industry needs to look beyond its cost…
Author
India is the hub of our R&D strength, process innovation and regulatory excellence
Jeevan Kasara, Chairman of the Board, STERIS Healthcare, believes India’s next pharma growth story will be built on trust,…
From scale to science: Ahmedabad’s pharma ecosystem at crossroads
The Formulation Development and Drug Delivery (FDD) Conclave has become a meeting ground for India's formulation R&D…
India’s race for the CDMO crown
For years, China+1 has been the big story in India's CDMO opportunity. Now, it is no longer enough. The shift away from China is…
Zydus gets final US FDA approval for Ascorbic Acid Injection with 180-Days CGT exclusivity
The product is primarily used for the short-term treatment of scurvy in adult and paediatric patients aged 5 months and older for…
India-US pharma ties look beyond generics
Sergio Gor, US Ambassador to India and Devendra Fadnavis, Maharashatra CM pitch deeper R&D, investment and co-development, at…
Inside Shilpa Medicare’s growth strategy: Quality, digital and global ambitions
Dr Vellaian Karuppiah, COO-Management, Shilpa Medicare shares his vision for building a future-ready organisation powered by…
Power, politics and pharma
In a world shaped by geopolitics, economic nationalism and heightened scrutiny on quality and resilience, India's next phase of…
FDD Leadership Awards spotlight FR&D excellence
Continuing its tradition of recognising excellence, the FDD Leadership Awards 2026, held alongside the FDD Conclave 2026,…
FDD Conclave 2026: Charting the future of formulation science and drug delivery
The pharma industry is entering an era where scientific innovation must move faster, scale smarter and remain affordable. Against…